Rayca Precision
Request a 1:1 Meeting with our directors to discuss your drug pipeline
Explore Partnership Opportunities
Partnership Models and Collaboration
Rayca Precision engages in highly focused collaborations with pharmaceutical and biotechnology organizations seeking novel therapeutic candidates across diverse disease areas. We do not license or sell our platform; instead, we deliver precisely crafted candidate libraries, meticulously optimized through our proprietary computational and experimental pipelines.
Target-Focused Alliances
We work with partners to define a specific therapeutic target or molecular pathway, then generate and refine customized libraries that exhibit high binding affinity, favorable ADMET profiles, and minimal off-target liabilities.
Therapeutic Area Collaboration
For companies aiming to expand or diversify a pipeline, we create comprehensive libraries tailored to key oncology, immunotherapy, or rare disease programs. This end-to-end approach compresses the timeline from concept to lead selection by leveraging extensive multi-omics insights.
Multi-Project Engagements
Longer-term alliances often involve multiple sequential or parallel projects, allowing our iterative discovery process—incorporating real-world data and emerging biomarkers—to refine and deliver successive candidate libraries with escalating precision.
Validation Studies
Throughout these collaborations, we provide continual scientific support, including data review, target validation insights, and guidance on subsequent validation studies, ensuring partners can swiftly progress high-potential leads into advanced preclinical and clinical development.
